All News

The vast majority of cancer survivors reported that they experience sexual side effects after chemotherapy, radiation and other cancer treatments according to the results of a survey presented at the annual meeting of the American Society for Radiation Oncology.

It has yet to be fully elucidated why postmenopausal women have a higher prevalence of benign paroxysmal positional vertigo (BPPV); however, the sudden decrease in estrogen during menopause can cause a rapid decrease in estrogen receptors, which may disturb otoconial metabolism and thus, increase the prevalence of BPPV.

Postmenopausal women with elevated hypertension who participated in the high-intensity team sport of floorball, a form of indoor hockey, achieved a significant decrease in their blood pressure.

The study in the Brazilian Journal of Nursing also found that the IUD complications were the same as those commonly cited in the literature.

The ever-use of an intrauterine device (IUD) reduces the risk of ovarian cancer by an average of 30%, according to a rigorous meta-analysis in the Journal of Obstetrics and Gynaecology.

This episode of Pap Talk by Contemporary OB/GYN features David Abel, MD, as he discusses various elements of skeletal dysplasia and how practitioners can help their patients.

We want to hear from you.

Moderna announced yesterday its plan to apply for emergency FDA authorization for its COVID-19 vaccine candidate.

The findings provide novel information on the outcome in pregnancy that are counter to smaller reports.

What to look for this week on Contemporary OB/GYN

It was a very busy week for the Contemporary OB/GYN team.

Officials with Operation Warp Speed said that COVID-19 vaccine distribution will begin 24 hours after the Food and Drug Administration's (FDA) approval.

Less than half of ob/gyns offer their patients the two most effective forms of emergency contraception -- ulipristal acetate and the copper intrauterine device (IUD) -- according to a national survey.

The risk of opioid use after endometriosis diagnosis is significantly greater in patients who used opioids before diagnosis, according to a retrospective analysis of data from a large health database.

The results of this retrospective study reflect experience with both vaginal and cesarean deliveries early in the pandemic, in comparison with similar periods in 2018 and 2019.

Heavily pretreated ovarian cancer patients who received a combination therapy of a novel engineered interleukin-2 (IL-2) cytokine plus pembrolizumab achieved an acceptable safety profile, according to a small cohort of an ongoing phase 1/2 trial.

Pregnant women with autoimmune-related interstitial lung disease (ILD) can have safe pregnancy outcomes if closely monitored by a multidisciplinary team of physicians.

The first Enhanced Recovery After Surgery (ERAS) guideline for standardizing and optimizing perioperative care for women undergoing minimally invasive gynecologic surgery (MIGS) has been published in The Journal of Minimally Invasive Gynecology.

What to look for this week on Contemporary OB/GYN

Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.

From vitamin D to calcium supplements and beta-blockers for bone loss density prevention, this slideshow from Rheumatology Network breaks it all down.

It was a very busy week for the Contemporary OB/GYN team.

A literature review has concluded that, although some studies find that vitamin K might increase bone mineral density (BMD) and reduce fracture risk in people with osteoporosis, the potential benefits of vitamin K supplements are not sufficiently supported.

Merck earned a new indication for pembrolizumab (Keytruda), in combination with chemotherapy, to treat locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC).

An analysis of CDC data presented at American Heart Association's Scientific Sessions 2020 suggests rates of high blood pressure complications during pregnancy nearly doubled during a period lasting from 2008-2017.

In this episode of Pap Talk, Contemporary OB/GYN Deputy Editor Jon I. Einarsson, MD, MPH, PhD, moderates a discussion with Robert K. Zurawin, MD, and Gaby Moawad, MD, on the new and existing surgical technologies and techniques available in ob/gyn.

A pandemic has challenged health care leaders like never before. Here’s how to get your team through it.

Findings from a retrospective study by researchers from NYU suggest that women with COVID-19 in pregnancy have an increased risk of placental abnormalities, regardless of whether their infection is symptomatic.